A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL)
A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL)
Recruiting · NCT04771507 · Registry updated 2021-02-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL) | B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 / Phase 2 | 2021-02-25 | NCT04771507 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jeanette Lundin | 1 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Akademiska hospital | Uppsala | Sweden | 2 |
| Falu lasarett | Falun | Sweden | 1 |
| Gävle Hospital | Gävle | Sweden | 1 |
| Karolinska University Hospital | Stockholm | Sweden | 35 |
| Norrland's University Hospital | Umeå | Sweden | 2 |
| Sahlgrenska University Hospital | Gothenburg | Sweden | 41 |
| Skåne University Hospital | Lund | Sweden | 1 |
| St Olavs Hospital | Trondheim | Norway | 5 |
| Örebro University Hospital | Örebro | Sweden | 5 |